Trial description:
A Phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV)-positive oropharyngeal cancer
Contact name:
Dr Ekpemi Irune
Trial start date:
Friday, June 16, 2017
Trial end date:
Friday, December 31, 2021
Trial tumour type:
Head & neck
Show on Radiotherapy:
Yes
